Tech Company Financing Transactions

Plasmonix Funding Round

Private investors participated in a $314.9 thousand capital raise for Plasmonix. This venture round was announced on 6/16/2014.

Transaction Overview

Company Name
Announced On
6/16/2014
Transaction Type
Venture Equity
Amount
$314,942
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9119 Gaither Rd.
Gaithersburg, MD 20877
USA
Email Address
Not Recorded
Overview
Plasmonix's focus is on enhancement of luminescent signals through advanced use of metal nanoparticles and application of its technology in life science and diagnostic assays.
Profile
Plasmonix LinkedIn Company Profile
Social Media
Plasmonix Company Twitter Account
Company News
Plasmonix News
Facebook
Plasmonix on Facebook
YouTube
Plasmonix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jesse Baumgold
  Jesse Baumgold LinkedIn Profile  Jesse Baumgold Twitter Account  Jesse Baumgold News  Jesse Baumgold on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/16/2014: Presidio Pharmaceuticals venture capital transaction
Next: 6/16/2014: Patch of Land venture capital transaction

 

Share this article

 


News on VC Transactions

We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary